Litcius/Paper detail

Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy

Cesare de Gregorio, Giancarlo Trimarchi, Denise Cristiana Faro, Fabrizio De Gaetano, Mariapaola Campisi, Valentina Losi, Concetta Zito, Corrado Tamburino, Gianluca Di Bella, Ines Monte

2023The American Journal of Cardiology32 citationsDOIOpen Access PDF

Abstract

Global left ventricular (LV) myocardial work (MW) indexes can be recognized at ultrasound imaging from the LV pressure/global longitudinal strain (GLS) loop analysis. A total of 4 indexes, global work index (GWI), global constructive work (GCW), global wasted work (GWW), and global work efficiency (GWE), have been demonstrated to overcome the methodological limitations of GLS and provide useful information on myocardial dysfunction in some clinical settings. Although impaired MW indexes have been demonstrated in patients with transthyretin cardiac amyloidosis (ATTR) or with nonobstructive hypertrophic cardiomyopathy (HCM), there are no comparative studies at present. This study aimed to describe the characteristics of MW in both these clinical settings compared with patients with well-controlled hypertension (HTN). A total of 83 patients, 32 with ATTR (aged 70 ± 11 years, 32% mutated, 68% wild-type, 72% men), 29 with HCM (aged 57 ± 17 years), and 22 HTN controls (aged 56 ± 5.6 years, 59% men) were prospectively enrolled at 2 clinical centers. All participants had New York Heart Association class I or II. Overall, the LV mass index was greater in both study groups than in HTN, whereas the LV ejection fraction (EF) was significantly lower in ATTR compared with other groups. Based on this finding, patients with ATTR were further divided into 2 subgroups: ATTR1 (LVEF ≤0.50), n = 14 (44%) and ATTR2 (LVEF >0.50), n = 18 (56%). Overall, the GWI and GCW were lower in all ATTR patients (mostly in ATTR1) than in the other groups (p <0.001), whereas only small differences in GWE and none in GWW were found among the groups. Of interest, the pairwise comparison and receiver operating characteristic analysis in preserved LVEF patients showed that GWI was a better discriminator of ATTR2 from HCM patients than GLS, with the cut-off value ≤1,419 mm Hg% (89% sensitivity; 55% specificity; p = 0.013). In conclusion, MW analysis was confirmed to be a modern way to investigate myocardial function in patients with hypertrophic phenocopies. GWI and GCW were more impaired in patients with ATTR compared with HCM and HTN controls. Furthermore, this study likely revealed an additional discriminative value of GWI over GLS alone in preserved LVEF settings. Global left ventricular (LV) myocardial work (MW) indexes can be recognized at ultrasound imaging from the LV pressure/global longitudinal strain (GLS) loop analysis. A total of 4 indexes, global work index (GWI), global constructive work (GCW), global wasted work (GWW), and global work efficiency (GWE), have been demonstrated to overcome the methodological limitations of GLS and provide useful information on myocardial dysfunction in some clinical settings. Although impaired MW indexes have been demonstrated in patients with transthyretin cardiac amyloidosis (ATTR) or with nonobstructive hypertrophic cardiomyopathy (HCM), there are no comparative studies at present. This study aimed to describe the characteristics of MW in both these clinical settings compared with patients with well-controlled hypertension (HTN). A total of 83 patients, 32 with ATTR (aged 70 ± 11 years, 32% mutated, 68% wild-type, 72% men), 29 with HCM (aged 57 ± 17 years), and 22 HTN controls (aged 56 ± 5.6 years, 59% men) were prospectively enrolled at 2 clinical centers. All participants had New York Heart Association class I or II. Overall, the LV mass index was greater in both study groups than in HTN, whereas the LV ejection fraction (EF) was significantly lower in ATTR compared with other groups. Based on this finding, patients with ATTR were further divided into 2 subgroups: ATTR1 (LVEF ≤0.50), n = 14 (44%) and ATTR2 (LVEF >0.50), n = 18 (56%). Overall, the GWI and GCW were lower in all ATTR patients (mostly in ATTR1) than in the other groups (p <0.001), whereas only small differences in GWE and none in GWW were found among the groups. Of interest, the pairwise comparison and receiver operating characteristic analysis in preserved LVEF patients showed that GWI was a better discriminator of ATTR2 from HCM patients than GLS, with the cut-off value ≤1,419 mm Hg% (89% sensitivity; 55% specificity; p = 0.013). In conclusion, MW analysis was confirmed to be a modern way to investigate myocardial function in patients with hypertrophic phenocopies. GWI and GCW were more impaired in patients with ATTR compared with HCM and HTN controls. Furthermore, this study likely revealed an additional discriminative value of GWI over GLS alone in preserved LVEF settings. The pathophysiology and management of cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) are unceasingly under investigation. Despite similarities in left ventricular (LV) chamber size and wall thickness on standard echocardiography investigation, discrepancies on LV function are detected by advanced imaging.1Mor-Avi V Lang RM Badano LP Belohlavek M Cardim NM Derumeaux G Galderisi M Marwick T Nagueh SF SenGupta PP Sicari R Smiseth OA Smulevitz B Takeuchi M Thomas JD Vannan M Voigt JU Zamorano JL. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography.Eur J Echocardiogr. 2011; 12: 167-205Crossref PubMed Scopus (748) Google Scholar,2Di Bella G Pizzino F Donato R Di Nunzio D de Gregorio C. Advanced non-invasive imaging techniques in chronic heart failure and cardiomyopathies: focus on cardiac magnetic resonance imaging and computed tomographic.Adv Exp Med Biol. 2018; 1067: 183-196Crossref PubMed Scopus (2) Google Scholar HCM is a genetic sarcomere disorder of the myocytes, often resulting in a variable tissue fibrosis, whereas CA is an interstitial disease caused by misfolded amyloid fibril deposit, with ensuing ceaseless electromechanical dysfunction. Amyloid disease is the consequence of a disorder involving the carrier protein called transthyretin, either genetically determined (transthyretin CA [ATTR] mutated [ATTRv]) or acquired (ATTR wild-type [ATTRwt]), as well as due to hematologic dyscrasia (amyloid light chain [AL] form). Typically, cardiac involvement is more frequent in the ATTRwt variant, largely affecting older male patients.3Maron BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google Scholar,4Garcia-Pavia P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google Scholar with or HCM often to for and or for clinical in the echocardiographic be patients LV mass and LV ejection fraction a greater in LV and function be found in Bella G Pizzino F Donato R Di Nunzio D de Gregorio C. Advanced non-invasive imaging techniques in chronic heart failure and cardiomyopathies: focus on cardiac magnetic resonance imaging and computed tomographic.Adv Exp Med Biol. 2018; 1067: 183-196Crossref PubMed Scopus (2) Google BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google Scholar ultrasound techniques provide as tissue and global longitudinal strain that can in a and treatment in the cardiac S J in heart PubMed Scopus Google M H A T Smiseth A clinical for of left ventricular loop a non-invasive index of myocardial Heart PubMed Scopus Google Scholar Although GLS well LV dysfunction in patients with hypertrophic from the analysis of loop myocardial work (MW) been as an advanced for myocardial function the GLS M H A T Smiseth A clinical for of left ventricular loop a non-invasive index of myocardial Heart PubMed Scopus Google Scholar MW a of myocardial the and and the as in J S B R A to myocardial work by non-invasive left ventricular in hypertension and Heart J PubMed Scopus Google S A D M R The of myocardial work in clinical Am Echocardiogr. PubMed Scopus Google value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and ejection Heart J PubMed Scopus Google Scholar Although studies on MW are from hypertrophic patients, comparative studies in patients with ATTR HCM are This study aimed to describe the characteristics of the MW indexes in both clinical settings and compared with patients with well-controlled to all patients to the heart failure at and for clinical or with ATTR or HCM were enrolled in this to the Society of the was on The of either or ATTRwt imaging at ultrasound or cardiac magnetic resonance and was confirmed by total 2 or genetic P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google Scholar with were HCM was on the Heart S A P J JA P C M MS Maron MS MW C for the and treatment of patients with hypertrophic cardiomyopathy: a of the of Heart Association on Google Scholar as LV wall thickness mm in in a chamber in the of to LV (2) of in of and nonobstructive for LV mm at The was of patients in hypertension to the RM C S EJ P B Thomas JD for the and management of in a of the of Heart Association on clinical 2018; PubMed Scopus Google Scholar a value of mm was in at The of a was recognized in both study groups. All participants had no of or heart heart A ultrasound was to echocardiography at both clinical centers. for cardiac chamber size and and MW analysis were at The standard were by 2 from and and C B JA RA for a echocardiographic in from the Society of Am Echocardiogr. PubMed Scopus Google Scholar The LV wall thickness from the to the to the hypertrophic cardiac chamber and were the to and the LVEF by the ultrasound function was the divided by the tissue as the value from the and as the was by the LV at under at the GLS and MW were a of GLS was at an ultrasound of and by an The LV loop analysis was to the MW indexes was the ultrasound the had been at for and an The MW indexes were at the as the of the C B JA RA for a echocardiographic in from the Society of Am Echocardiogr. PubMed Scopus Google Scholar to from the and Society of the MW indexes were as global work index mm is the total work from the and (2) global constructive work mm is the MW LV global wasted work mm is the work LV and with no to cardiac and global work efficiency mm is the GCW and the of GCW J S B R A to myocardial work by non-invasive left ventricular in hypertension and Heart J PubMed Scopus Google S A D M R The of myocardial work in clinical Am Echocardiogr. PubMed Scopus Google D T A B S C C A The non-invasive of myocardial work by clinical 2022; PubMed Scopus Google Scholar are as ± or ± standard are as and The comparison 2 or more groups for were the analysis of on was for were compared the for and the for pairwise analysis. operating characteristic were for patients with ATTR from with HCM by GWI and GLS The under the and were from the and standard The for MW and GLS was on a of patients by the on The was at 2 for p to the echocardiographic The the of the all information to be A total of 83 patients, 32 with ATTR 70 ± 11 years), 29 with HCM 57 ± 17 and 22 HTN controls 56 ± 5.6 were and clinical characteristics are in from in HTN HTN was recognized in some patients from both study in the HCM patients and had New York Heart Association class and had or A total of 22 patients with ATTR were as ATTRwt and were these patients were older than with HCM and controls (p differences were heart at and LV mass index the study and clinical characteristics of the study = = ± ± ± ± ± ± ± ± ± or in a with or are as ± or = = = or in a with or in a are as ± or = = = The echocardiographic and MW indexes are in chamber size and LV mass index were greater in patients with ATTR and HCM than in controls. LV ejection fraction and were lower in the ATTR of some patients had LVEF This that the LV was greater in size than in patients with HCM and HTN all had LVEF GLS was impaired in both study groups than in HTN, in ATTR the (p = as well as GWI and GCW (p GWE was lower in patients with ATTR and HCM than in there was no the echocardiographic index ± ± ± index ± ± ± index ± ± ± ejection fraction ± ± ± ± ± ± mass index ± ± ± ± ± ± longitudinal GLS ± ± ± work GWI ± ± ± constructive GCW ± ± ± wasted GWW ± ± ± work GWE ± ± ± are value ± were at = transthyretin cardiac HCM = hypertrophic HTN = = tissue LV = left in a are value ± were at ATTR = transthyretin cardiac HCM = hypertrophic HTN = = tissue LV = left In to the of a for GWI mm Hg% in patients with H B F J S of left ventricular myocardial work in cardiac Heart J PubMed Scopus Google Scholar lower were found in of of and of HCM in none in patients with HTN (p the of patients with ATTR with impaired LVEF to the Heart Association B D A P MS CA for the management of heart a of the of Heart Association on 2022; Google Scholar divided patients into 2 subgroups: with LVEF = and (2) ATTR2 = with LVEF MW were impaired in the with a GWI of ± mm Hg% in patients with ATTR1 ± mm Hg% in ATTR2 (p = GCW was ± ± mm Hg% (p = small differences in GWE and none in GWW were found among groups as well as LV mass index was at ± ± p = the pairwise evaluation of the heart failure with preserved ejection fraction as ATTR2 HCM more confirmed GWI as the discriminator of from sarcomere with a value of ± mm Hg% in ATTR2 ± mm Hg% in patients with HCM (p The of GWI was further at the with an value of mm Hg% and under the = compared with GLS Overall, the for the MW and GLS was The index was for GWI mm for GCW mm for GWW mm for GWE mm and for MW analysis an in the ultrasound of LV function in cardiac J S B R A to myocardial work by non-invasive left ventricular in hypertension and Heart J PubMed Scopus Google S A D M R The of myocardial work in clinical Am Echocardiogr. PubMed Scopus Google D T A B S C C A The non-invasive of myocardial work by clinical 2022; PubMed Scopus Google Scholar are from studies to better the and of the myocardial wall in clinical hypertrophic H B F J S of left ventricular myocardial work in cardiac Heart J PubMed Scopus Google F C C U V J G S of left ventricular myocardial work in patients for heart PubMed Scopus Google P M V work in nonobstructive hypertrophic cardiomyopathy: for Am Echocardiogr. PubMed Scopus Google G M E M G F R F G E G P P P G Global left ventricular myocardial work efficiency in heart failure patients with cardiac and in Google Scholar the indexes, this study that myocardial is significantly impaired in of and in patients with ATTR and HCM compared with HTN controls are to have some of myocardial M C S V G C The of left ventricular on myocardial work in 2022; PubMed Scopus Google Scholar In to by the for R S R F T S S A G D M Cardim A T de G M T JD de D Zamorano M A M J B E E S C C Galderisi M Badano LP Lang RM C P for non-invasive myocardial work from the Heart J PubMed Scopus Google Scholar The and GWE were impaired in HTN controls. The in study were GWI and and the likely confirmed value for a better of the of LV in preserved LVEF settings as in ATTR2 and at for advanced disease BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google Scholar,4Garcia-Pavia P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google Scholar In these patients, the analysis that GWI value ≤1,419 mm Hg% can from sarcomere cardiomyopathy with with likely of the characteristics of Bella G Pizzino F Donato R Di Nunzio D de Gregorio C. Advanced non-invasive imaging techniques in chronic heart failure and cardiomyopathies: focus on cardiac magnetic resonance imaging and computed tomographic.Adv Exp Med Biol. 2018; 1067: 183-196Crossref PubMed Scopus (2) Google BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google P M V work in nonobstructive hypertrophic cardiomyopathy: for Am Echocardiogr. PubMed Scopus Google Scholar Despite the in and GWE among the was to in is caused by a of In this are in with the by G M E M G F R F G E G P P P G Global left ventricular myocardial work efficiency in heart failure patients with cardiac and in Google Scholar found no differences in GWW patients with ATTRwt and controls ± ± p = In GLS a of LV dysfunction in clinical the Nunzio D A de Gregorio C C S Di Bella in cardiac and strain PubMed Scopus Google A D A Desai value of global longitudinal strain in hypertrophic cardiomyopathy: a of 12: PubMed Scopus Google Scholar be that MW indexes from GLS, and the of the value of MW in the loop of the heart in cardiac J S B R A to myocardial work by non-invasive left ventricular in hypertension and Heart J PubMed Scopus Google S A D M R The of myocardial work in clinical Am Echocardiogr. PubMed Scopus Google value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and ejection Heart J PubMed Scopus Google D T A B S C C A The non-invasive of myocardial work by clinical 2022; PubMed Scopus Google Scholar Of interest, the of GWI mm Hg% and GLS from analysis be for ATTR and HCM and to be in study H B F J S of left ventricular myocardial work in cardiac Heart J PubMed Scopus Google Scholar found that patients with amyloid disease and GWI mm Hg% were at a of mm study of to these a GWI value mm Hg% in of patients with of and of of a This that is the and to interstitial of misfolded in patients with ATTR and likely a P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google H B F J S of left ventricular myocardial work in cardiac Heart J PubMed Scopus Google A S F and tissue in cardiac to myocardial and to light chain amyloid Heart PubMed Scopus Google Y of cardiac J PubMed Scopus Google Scholar Despite the of myocardial were found with significantly tissue and and Y of cardiac J PubMed Scopus Google Scholar to LV dysfunction and than ATTR these patients a as confirmed by the for GWW in Amyloid only the the G de F M V Di Bella G C de Gregorio C. strain imaging by the value in cardiac amyloidosis and hypertrophic Google Scholar cardiac and Bella G F R P M D F M de Gregorio C F A C F G S and value of echocardiographic in cardiac 2022; PubMed Scopus Google Scholar with the disease and disease to a greater compared with patients with nonobstructive U G R R G A cardiac in hypertrophic of and myocardial Heart PubMed Scopus Google A F R and as of dysfunction in patients from the transthyretin amyloidosis PubMed Scopus Google Scholar patients with ATTR are to are for patients with HCM and HTN are of BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google S A P J JA P C M MS Maron MS MW C for the and treatment of patients with hypertrophic cardiomyopathy: a of the of Heart Association on Google Scholar clinical are from modern treatment of ATTR misfolded P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google Y D V T I Rapezzi C Y M G Merlini and in the and of 2022; PubMed Scopus Google of and for amyloid transthyretin J Cardiol. 2022; PubMed Scopus Google Scholar Although the is in patients with nonobstructive HCM than in the the clinical in the of are or patients with HCM can be or have for years, with preserved LV function for a Diagnosis is often on or and patients are that are of an BJ Desai MY Nishimura RA Spirito P Rakowski H Towbin JA Dearani JA Rowin EJ Maron MS Sherrid MV. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022; 79: 390-414Crossref PubMed Scopus (97) Google S A P J JA P C M MS Maron MS MW C for the and treatment of patients with hypertrophic cardiomyopathy: a of the of Heart Association on Google MS R of hypertrophic cardiomyopathy in the J Cardiol. PubMed Scopus Google Scholar In these other than cardiac resonance Bella G Pizzino F Donato R Di Nunzio D de Gregorio C. Advanced non-invasive imaging techniques in chronic heart failure and cardiomyopathies: focus on cardiac magnetic resonance imaging and computed tomographic.Adv Exp Med Biol. 2018; 1067: 183-196Crossref PubMed Scopus (2) Google Scholar echocardiography is a of the and advanced techniques as GLS and MW further to LV C B JA RA for a echocardiographic in from the Society of Am Echocardiogr. PubMed Scopus Google D T A B S C C A The non-invasive of myocardial work by clinical 2022; PubMed Scopus Google A D A Desai value of global longitudinal strain in hypertrophic cardiomyopathy: a of 12: PubMed Scopus Google Scholar The the by E E F V A M E constructive work is impaired in hypertrophic cardiomyopathy and left ventricular PubMed Scopus Google Scholar found significantly impaired GCW GWW in patients with HCM = ± mm compared with ± mm p <0.001), is with the of interstitial P M V work in nonobstructive hypertrophic cardiomyopathy: for Am Echocardiogr. PubMed Scopus Google Scholar the GCW to to wall thickness in whereas the GWW in the and was to the of LV A the differences found in GWI patients with HCM and ATTR2 is the in the of sarcomere hypertrophic of been in to the of that of and H M R JD Y JA A of sarcomere hypertrophic cardiomyopathy in PubMed Scopus Google S MS S The and the of caused by hypertrophic cardiomyopathy Biol. PubMed Scopus Google Scholar This likely the better GWI as of the total ventricular work at in patients with preserved This study be in light of and for ultrasound and of Although the for MW is by a small in the of GLS and can in a imaging from echocardiographic is M H A T Smiseth A clinical for of left ventricular loop a non-invasive index of myocardial Heart PubMed Scopus Google J S B R A to myocardial work by non-invasive left ventricular in hypertension and Heart J PubMed Scopus Google S A D M R The of myocardial work in clinical Am Echocardiogr. PubMed Scopus Google value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and ejection Heart J PubMed Scopus Google Scholar and the of the for MW there were to a of the study and a in clinical for the of provide was The was by the of patients with ATTR to the and this was of the patients had that a myocardial than P Rapezzi C Adler Y Arad M Basso C Brucato A Burazor I Caforio ALP Damy T Eriksson U Fontana M Gillmore JD Gonzalez-Lopez E Grogan M Heymans S Imazio M Kindermann I Kristen AV Maurer MS Merlini G Pantazis A Pankuweit S Rigopoulos AG Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the Society of on and J Heart PubMed Scopus Google H B F J S of left ventricular myocardial work in cardiac Heart J PubMed Scopus Google Scholar of the of investigate further or the of the LV chamber in size and in MW indexes were is to the of on as a ATTR was older than the and this to the greater MW in studies on the for MW indexes in the in HCM and in patients with ATTR are In conclusion, this study the of MW indexes in the of LV dysfunction in hypertrophic phenocopies. GWI and GCW were more impaired in patients with ATTR than in with HCM and LV and in both groups than in HTN controls. Although GLS an in an value of GWI in patients with ATTR2 from patients with both with preserved studies are to the and light on the The have no to

Topics & Concepts

Ejection fractionMedicineCardiologyInternal medicineHypertrophic cardiomyopathyCardiac amyloidosisCardiomyopathyTransthyretinHeart failureLeft ventricular hypertrophyAmyloidosisBlood pressureAmyloidosis: Diagnosis, Treatment, OutcomesCardiovascular Function and Risk FactorsCardiomyopathy and Myosin Studies